Ostomycure AS is a medical technology company, developing an innovative new solution for evacuating of fluids from the intestines. The technology is called Transcutaneous Evacuation Implant Technology, TIES™. The TIES™ technology is aimed to be an alternative for patients with inflammatory conditions in colon, cancer in the urinary bladder and cancer in rectum.
Ostomycure has just entered the clinical trial phase. In the pre-clinical phase Ostomycure showed, as the first company ever, that it is possible to get a good in-growth between intestine and a titanium implant.

Ostomycure is based at Science Park in Oslo and is partnering with Karolinska University Hospital, Huddinge, Sweden, Rikshospitalet in Oslo, Norway, Norrlands University Hopsital in Umeå, Sweden, Ahus Hospital in Oslo, Norway and a number of other commercial partners.